ArticleRMD open2020

Changes in selected haematological parameters associated with JAK1/JAK2 inhibition observed in patients with rheumatoid arthritis treated with baricitinib.

Jonathan Kay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.